Articles
-
Brochure: XD® Technology: Improve Biopharmaceutical Production
2/22/2012
DSM's XD® Technology has been developed to drive yield improvements in the production of biopharmaceuticals.
-
Brochure: Finished Dosage Forms
2/21/2012
DSM is a global provider of finished dosage form manufacturing and related services to pharmaceutical and biopharmaceutical markets.
-
Exclusive Synthesis For Crop Protection
1/30/2012
DSM provides custom manufacturing of advanced intermediates and active pharmaceutical ingredients.
-
Brochure: Biologics Contract Manufacturing & Technology Solutions
1/30/2012
DSM provides turn-key biologic manufacturing solutions, contract manufacturing for preclinical development, clinical trials or commercial supply and reduced cost, risk, and time to market.
-
Brochure: Pharma Sterile Dosage Forms
1/30/2012
DSM offers pharmaceutical and biopharmaceutical customers a lyophilization system with unique benefits. It has the precision to serve increasingly demanding lyophilization cycles, a critical requirement for successful product launches and high commercial yields.
-
Combination Products 2.0: Applying The New FDA Regulations
1/20/2012
Combination products, those that contain medical devices embedded with pharmaceutical or biologic components, have become a large and growing segment of the medical device market. Some analysts estimate they represent over 30% of all new product submissions to the FDA. By Steven Richter, Ph.D
-
Veteran Guidance On The CMO Selection Process From James Bruno
11/11/2011
Life Science Leader magazine put together an executive roundtable article on the CMO selection process for a 2011 special supplement. The intent – to gain a better understanding of the some of the challenges faced during the partnering and provide insights on how to overcome. I received some great responses from James Bruno managing director, Chemical and Pharmaceutical Solutions and Chemical Consultants. By Rob Wright
-
Executive Insights Into CMO Selection: Greg Troiano, BIND Biosciences
11/11/2011
Life Science Leader magazine put together an executive roundtable article on the CMO selection process for a 2011 special supplement. The intent — to gain a better understanding of the some of the challenges faced during the partnering and provide insights on how to overcome. By Rob Wright
-
MTOSoftgels: Providing Cohort Specific Hand Filled Softgel Capsules For Dose Escalation Studies
11/2/2011
Formulation and automated manufacture of capsules for early phase dose escalation clinical trials can be costly and wasteful. By Lisa Z Crandall
-
Alkermes Contract Pharma Services
9/28/2011
With Alkermes Contract Pharma Services, you have the opportunity to outsource your development, scale-up and manufacturing requirements to a trusted, experienced and dedicated expert in outsourcing services.